23 March 2010 in European Radiology
19 February 2009 in Medical Physics
1 July 2007 in American Journal of Roentgenology
OBJECTIVE. The purpose of our study was to determine the attenuation of colorectal polyps on portal phase contrast-enhanced CT colonography (CTC) and evaluate whether enhanced polyps can be clearly distinguished from tagged feces during CTC review. MATERIALS AND METHODS. Our institutional review board approved this study and waived patient informed consent. Forty-eight colonoscopy-proven polyps (6–20 mm) and 41 polypoid tagged feces (6–19 mm) were selected from contrast-enhanced CTC performed without (n = 37 examinations) and with (n = 10 examinations) fecal tagging, respectively. Scanning was performed 72 seconds after IV injection of 150 mL of contrast material at a rate of 2.5 mL/s. Fecal tagging consisted of three doses of 200 mL of 5% weight/volume (w/v) barium sulfate suspension taken at each meal the day before CTC. Attenuation of the polyps and tagged feces was measured. Four independent blinded radiologists reviewed the polyps and tagged feces at both wide (width, 1,500 H; level –400 H) and soft-tissue (width, 400 H; level, 20 H) window settings to distinguish them by using subjective visual assessment. RESULTS. Polyp attenuation on the portal phase was not correlated with size (R = –0.003; p = 0.99) and was not different between histologic types (p = 0.884). Enhanced polyps (mean ± SD, 119.9 ± 25.3 H; range, 50–173 H) showed significantly lower attenuation than did tagged feces (1,521.4 ± 683.6 H; range, 495–2,683 H) without any overlap (p < 0.0005). An 8-mm sessile adenomatous polyp was misinterpreted as tagged feces by one reviewer. The rest of the lesions were correctly interpreted by all reviewers, resulting in high interobserver agreement (kappa value, 0.988). CONCLUSION. Polyp attenuation on portal phase contrast-enhanced CTC ranges from 50 to 173 H. Contrast-enhanced polyps are clearly and consistently distinguished from barium-tagged polypoid feces.
1 June 2013 in American Journal of Roentgenology
OBJECTIVE. The purpose of this study was to determine the prevalence and CT findings of afferent jejunal loop varices after bilioenteric anastomosis in patients with malignancy. MATERIALS AND METHODS. The study included 99 patients who underwent bilioenteric anastomosis for malignancy and follow-up CT examinations. Two abdominal radiologists reviewed CT images for the presence of afferent loop varices. They also assessed for the presence of extrahepatic portal occlusion or stenosis, other collateral vessels, ascites, splenomegaly, and recurrent tumor. Clinical data regarding age, sex, and histories of pancreaticoduodenectomy and surgery on the portal vein, radiation therapy, and postoperative gastrointestinal bleeding were collected. Univariate and multivariate analyses were performed to discern significant factors associated with afferent loop varices. Cumulative incidence was estimated with the Kaplan-Meier method. RESULTS. Afferent loop varices were found in 22 of the 99 patients (22.2%), and the 48-month cumulative incidence of afferent loop varices was 28.0%. Three of the 22 patients (13.6%) eventually experienced gastrointestinal bleeding. Obstruction in the extrahepatic portal system was the only feature that exhibited a significant difference in multivariate analysis (relative risk, 71.4; 95% CI, 7.4–1000). CONCLUSION. Afferent loop varices detected after bilioenteric anastomosis on CT images had a prevalence of 22.2% and can result in gastrointestinal bleeding. The presence of obstruction in the extrahepatic portal system was significantly associated with afferent loop varices.